Dr Mark H Seipel, OD - Medicare Optometrist in Norfolk, VA

Dr Mark H Seipel, OD is a medicare enrolled "Optometrist" provider in Norfolk, Virginia. His current practice location is 7525 Tidewater Dr, Suite 41, Norfolk, Virginia. You can reach out to his office (for appointments etc.) via phone at (757) 588-5423.

Dr Mark H Seipel is licensed to practice in Virginia (license number 0618000125) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1154418564.

Contact Information

Dr Mark H Seipel, OD
7525 Tidewater Dr, Suite 41,
Norfolk, VA 23505-3700
(757) 588-5423
(757) 588-6012



Healthcare Provider's Profile

Full NameDr Mark H Seipel
GenderMale
SpecialityOptometrist
Location7525 Tidewater Dr, Norfolk, Virginia
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1154418564
  • Provider Enumeration Date: 10/06/2006
  • Last Update Date: 06/09/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 3971676206
  • Enrollment ID: I20080721000290

Medical Identifiers

Medical identifiers for Dr Mark H Seipel such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154418564NPI-NPPES
9234861MedicaidVA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 0618000125 (Virginia)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mark H Seipel allows following entities to bill medicare on his behalf.
Provider NameDr John C Dragon Od & Associates
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1720177322
PECOS PAC ID: 6103999677
Enrollment ID: O20080716000363

News Archive

Significant breakthrough in understanding the cause of bile duct cancer

A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.

BioPharmX submits request for pre-IND meeting to FDA for topical antibiotic acne compound

BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.

Australian researchers identify potential target to fight tumours

Dr Guishui Zhang and Associate Professor Levon Khachigian, from the Centre for Vascular Research, and Dr Nick Di Girolamo of the School of Medical Sciences were part of a team which suppressed a protein in the cells lining blood vessels.

Cambrex wins the CPhI Innovation Award for its Continuous-Flow Microwave-Assisted Organic Synthesis technology

Cambrex Corporation announced today that it won the Silver Innovation Award at the 2009 CPhI Event for its Continuous-Flow Microwave-Assisted Organic Synthesis (CFMAOS) technology. The award was accepted by Dr. Jayne E. Muir (Market Research & New Technologies - Europe), who presented the technology to a panel of judges at this important pharmaceutical ingredients exhibition in Madrid, Spain on October 13, 2009.

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark H Seipel is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Mark H Seipel, OD
7525 Tidewater Dr, Suite 41,
Norfolk, VA 23505-3700

Ph: (757) 588-5423
Dr Mark H Seipel, OD
7525 Tidewater Dr, Suite 41,
Norfolk, VA 23505-3700

Ph: (757) 588-5423

News Archive

Significant breakthrough in understanding the cause of bile duct cancer

A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.

BioPharmX submits request for pre-IND meeting to FDA for topical antibiotic acne compound

BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.

Australian researchers identify potential target to fight tumours

Dr Guishui Zhang and Associate Professor Levon Khachigian, from the Centre for Vascular Research, and Dr Nick Di Girolamo of the School of Medical Sciences were part of a team which suppressed a protein in the cells lining blood vessels.

Cambrex wins the CPhI Innovation Award for its Continuous-Flow Microwave-Assisted Organic Synthesis technology

Cambrex Corporation announced today that it won the Silver Innovation Award at the 2009 CPhI Event for its Continuous-Flow Microwave-Assisted Organic Synthesis (CFMAOS) technology. The award was accepted by Dr. Jayne E. Muir (Market Research & New Technologies - Europe), who presented the technology to a panel of judges at this important pharmaceutical ingredients exhibition in Madrid, Spain on October 13, 2009.

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

Read more News

› Verified 9 days ago


Optometrist in Norfolk, VA

Dr. Laura Li, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 549 E Brambleton Ave, Norfolk, VA 23510
Phone: 757-533-9441    
Sea Eye Care
Optometrist
Medicare: Medicare Enrolled
Practice Location: 9573 Shore Dr Ste E, Norfolk, VA 23518
Phone: 757-644-7234    Fax: 757-296-0839
Walter O Whitley, MD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 241 Corporate Blvd, Norfolk, VA 23502
Phone: 757-622-2200    Fax: 757-622-4866
Dr. Nathalie Cassis,
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 335 W 21st St, Norfolk, VA 23517
Phone: 757-622-3937    Fax: 757-596-6947
Dr. Emily Scannell, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1560 Mall Dr, Norfolk, VA 23511
Phone: 757-440-1075    Fax: 757-440-1168
Dr. Thomas Schlater,
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1035 Nider Blvd, Norfolk, VA 23521
Phone: 757-314-7413    
Dr. John Christopher Dragon, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 7525 Tidewater Dr, Suite 41, Norfolk, VA 23505
Phone: 757-588-5423    Fax: 757-588-6012

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.